<b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=''1px''><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
ANG Lifesciences India Ltd has informed BSE that the company does not fall under the category of 'Large Corporate' for financial year 2025-26. As a result, the requirement to file Annual Disclosure under SEBI's Large Corporate guidelines is not applicable to the company. The disclosure references SEBI Circular SEBI/HO/DDHS-RACPOD1/P/CIR/2023/172 dated October 19, 2023 and earlier circulars governing fund-raising through debt securities. The company has committed to inform BSE and fulfill all requirements if it subsequently falls under the Large Corporate criteria in the future.
Neutral for shareholders. This filing confirms the company is below SEBI's threshold for Large Corporate classification, meaning lower regulatory borrowing disclosure requirements. It indicates the company has relatively modest debt levels relative to its size.